what will be uncertained is clune and the lobbies are feeing on who is going to be hit. >> there is philosophicaladle in congress before the prices? >> the typical move that congress does is it says, let'ss study it. let's commission some agency to do a study to see how can be lower prices? and that's essentially what the one piece of legislation is proposing that something called -- it was a program that was passed to try to create more patient safety, but ultimately it's been a way for brand idaho protect their market share, and one piece of legislation that is considered popular that would study the problems when there's all kind of evidence that it's being abused be plannedded companies to protect their industry shares. the most likely thing is another study and push it down the road. >> even the president weighed in, early in his administration, shortly after he took offers when he met with pharmaceutical company ceos to talk about the issue. we'll show you bit from january. >> the competition, the key to lower drug prices. anything that make is harder for smaller and younger toys to take th